|
Office Locations:
|
565 Fifth Ave, 26th Floor
New York, NY 10017
Phone: 212-981-6901
Fax: 212-918-9378
| | |
|
|
|
Information Technology
Life Sciences & Healthcare
|
|
|
Health Enterprise Partners, L.P. (HEP) is a lower middle market private equity firm focused exclusively on investments in healthcare services and technology businesses. In addition to a number of financial investors, HEP has aggregated capital from an extensive network of payers, providers and healthcare organizations across its three funds. Together, this group of 40 industry participants represents 300 hospitals and 125 million covered lives and employs 850,000 people throughout the United States. These strategic investors help the firm target attractive market segments, identify and evaluate investment opportunities, and support the growth of its portfolio companies. Over $600 million has been committed to HEP Funds. HEP's investment professionals have deep domain knowledge, operational experience, and a proven track record as investors. The firm is a committed partner, providing management with market connectivity and support that contribute to the growth of the business and a successful liquidity event. HEP believes innovation in healthcare will translate into both improvements in patient care and superior returns for its investors. The firm generally does not invest in pre-revenue companies, preferring investment sizes up to $5 - $15 million in companies that are profitable or have a very clear path to profitability within 12 to 18 months.
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|